Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Figure 1 Overview of Markov model for infected total hip arthroplasty

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Lecture 11 serology Lyme’s Disease

Table 1 Organisms for which rapid identification criteria are included. From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee.

Table 1 Characteristics of the 968 Women in the Study Group

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

From: Rotarix: A Rotavirus Vaccine for the World

Laboratory diagnosis and biosafety issues of biological warfare agents

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

From: Postinfectious Irritable Bowel Syndrome

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Figure 2 In situ hybridization for rhinovirus type 14 (rhinovirus-14) in maxillary sinus biopsy specimens. A, Detection of rhinovirus-14, antisense probe,

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,

P. Dabir, S. Dabir, K.N. Krithika, K. Goswami, M.V.R. Reddy

Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein–Barr virus serologic.

Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay Q. Yuan, X.-D. Cheng, B.-C.

KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics E. Tornero, L. Morata,

Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis

Hepatitis Primary Care: Clinics in Office Practice

Approach to diagnosis of infective endocarditis

Serological testing for Bartonella henselae infections in The Netherlands: clinical evaluation of immunofluorescence assay and ELISA M.J. Vermeulen,

Herpes zoster in non-hospitalized children

Cross-reaction between Yersinia outer membrane proteins and anti-Borreli antibodies in sera of patients with Lyme disease E. Golkocheva-Markova, I. Christova,

Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area Nora Cardona-Castro, Piedad Agudelo-Flórez

A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti- toxoplasma IgG avidity test P. Flori, B. Bellete, C. Crampe, A.

A serosurvey of Orientia tsutsugamushi from patients with scrub typhus

Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus P.-R. Hsueh, L.-M. Huang, P.-J.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Assessment of the cag pathogenicity island status of Helicobacter pylori infections with serology and PCR M. Kivi, Y. Tindberg, C. Bengtsson, L. Engstrand,

Toxoplasmic lymphadenitis—clinical and serologic profile

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Results from a mathematical model for human monocytic ehrlichiosis

Vector control: a cornerstone in the malaria elimination campaign

B.F.C. Sampaio, M.S. Macre, L.R. Meireles, H.F. Andrade

Training for the infectious diseases speciality in Norway

T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini

Laboratory diagnosis and biosafety issues of biological warfare agents

Chagas disease in the immunosuppressed patient

Metagenomics and probiotics

Prospective evaluation of a dot-blot enzyme immunoassay (Directigen RSV) for the antigenic detection of respiratory syncytial virus from nasopharyngeal.

Laboratory diagnosis of Clostridium difficile disease

G.R. Davies Clinical Microbiology and Infection

Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations T.T.H. Hoang, A.-S. Rehnberg,

Abstracts cont. Clinical Microbiology and Infection

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

D. Hvidsten, D.S. Halvorsen, B.P. Berdal, T.J. Gutteberg

Karine Ryffel, Olivier Péter, Luc Binet, Eric Dayer

Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Q Fever: Epidemiology, Diagnosis, and Treatment

D. Baud, C. Kebbi, J.-P. Külling, G. Greub

Enhanced isolation of Legionella species from composted material

The future of diagnostic bacteriology

Presentation transcript:

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme disease, in areas of the United States where the disease is endemic. From: A Limitation of 2-Stage Serological Testing for Lyme Disease: Enzyme Immunoassay and Immunoblot Assay Are Not Independent Tests Clin Infect Dis. 2000;30(3):545-548. doi:10.1086/313688 Clin Infect Dis | © 2000 by the Infectious Diseases Society of America

Table 2 Correlation between the number of bands on IgM immunoblot and the reactivity of IgM ELISA kits A and B on sera of persons without Lyme disease. From: A Limitation of 2-Stage Serological Testing for Lyme Disease: Enzyme Immunoassay and Immunoblot Assay Are Not Independent Tests Clin Infect Dis. 2000;30(3):545-548. doi:10.1086/313688 Clin Infect Dis | © 2000 by the Infectious Diseases Society of America

Table 3 Positive predictive value of sequential testing in early Lyme disease, with IgM ELISA followed by IgM immunoblot assay (IB). From: A Limitation of 2-Stage Serological Testing for Lyme Disease: Enzyme Immunoassay and Immunoblot Assay Are Not Independent Tests Clin Infect Dis. 2000;30(3):545-548. doi:10.1086/313688 Clin Infect Dis | © 2000 by the Infectious Diseases Society of America